Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy Ltd has informed BSE that its Board of Directors will meet on Friday, 13 February 2026 at 01:00 PM at the registered office in Kala Amb, Himachal Pradesh. The main agenda is to consider, approve, and take on record the Unaudited Standalone Financial Results along with the Limited Review Report for the quarter ended 31 December 2025. The filing is made under Regulation 29(1) of SEBI LODR, 2015, and is also addressed to MSE. No financial figures or business details are disclosed in this intimation; only routine matters may also be discussed.
This is a routine procedural intimation with no price-moving information. Investors should await the actual Q3 FY26 results to be published after the board meeting to assess financial performance.